The tool — called the Mykrobe Predictor software — was developed to be used on a laptop or tablet without the need for any specialist expertise. Once a bacterial sample has been cultured and its DNA sequenced, the software can analyze the genetic code in a matter of minutes.
The program was already tested using 4,500 patient samples. The study, published in the journal Nature Communications, shows the program was able to identify antibiotic resistance in two dangerous bacterial infections: Staphylococcus aureus and tuberculosis.
Now, Mykrobe Predictor is being tested in three U.K. hospitals to see whether it has the potential to accelerate the diagnosis of drug-resistant infections and help physicians better target antibiotic prescriptions.
“Genome sequencing has the potential to transform the way we diagnose and treat bacterial infections in NHS hospitals, but one of the main challenges is developing the right tools to enable us to unlock this information quickly and affordably,” said co-author Derrick Crook. “Our ultimate goal is to be able to provide complete information on a pathogen within 24 hours of culture, linking this information to a national surveillance database to enable more timely and better targeted patient treatment.”
To check out how the program works, watch the video below.
More articles on infection control:
Top 10 infection control stories, January 4-8
Scripps expands ambassador program to put heart pump patients at ease before surgery
‘We must take action now’ and 4 other thoughts on antibiotic resistance from CDC Director Dr. Tom Frieden
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.